Evidence map›Paper›PMID 16274482›Full record

ArticleRetrovirology2005

Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.

Hong Zhang, Federico Hoffmann, Jun He, Xiang He, Chipepo Kankasa, Ruth Ruprecht, John T West, Guillermo Orti, Charles Wood

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Hong ZhangNebraska Center for Virology, University of Nebraska, Lincoln, NE, USA. hongz@unlserve.unl.edu
Federico Hoffmann
Jun He
Xiang He
Chipepo Kankasa
Ruth Ruprecht
John T West
Guillermo Orti
Charles Wood
University of Nebraska–Lincoln · USDana-Farber Cancer Institute · USUniversity Teaching Hospital · ZM

Funding

Virology and ImmunologyP01AI048240 · NIAID · UNIVERSITY OF WASHINGTON · PI LAKHASHE, SAMIR KISHOR · 2000 to 2020
$46.7M
VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI ZHENG, JIALIN CHARLES · 2000 to 2009
$22.1M
Infant Immunoprophylaxis against a Primate LentivirusR37AI034266 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI RUPRECHT, RUTH MARGRIT · 2003 to 2012
$7.7M
Supplement: Fogarty Training in HIV- and AIDS Associated Diseases/MalignanciesD43TW001429 · FIC · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2015
$7.2M
Evolution of Clade C HIV-1 in Infected ChildrenR01HD039620 · NICHD · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2001 to 2005
$1.6M
FETAL IMMUNOPROPHYLAXIS AGAINST A PRIMATE LENTIVIRUSR01AI034266 · NIAID · DANA-FARBER CANCER INSTITUTE · PI RUPRECHT, RUTH MARGRIT · 1994 to 2001
$1.1M
INTERACTIONS BETWEEN HIV AND KSHVR01CA076958 · NCI · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 1998 to 2001
$434k
FIC NIH HHS D43 TW001429FIC NIH HHS TW01429NCI NIH HHS CA76958NCRR NIH HHS P20 RR015635NCRR NIH HHS RR15635NIAID NIH HHS P01 AI048240NIAID NIH HHS P01 AI34266NIAID NIH HHS P01 AI 48240NIAID NIH HHS R01 AI034266NICHD NIH HHS HD39620NICHD NIH HHS R01 HD039620
6 · The paper itself

Abstract

backgroundGiven the high prevalence of mother to child infection, the development of a better understanding of African subtype C HIV-1 transmission and natural evolution is of significant importance. In this study, we genotypically and phenotypically characterized subtype C viruses isolated over a 67-month follow-up period from an in utero-infected Zambian infant. Changes in genotype and phenotype were correlated to alterations of the host humoral immune response.

resultsA comparison of baseline maternal and infant samples indicated that the infant sequences are monophyletic and contain a fraction of the diversity observed in the mother. This finding suggests that selective transmission occurred from mother to child. Peaks in infant HIV-1 Env genetic diversity and divergence were noted at 48 months, but were not correlated with changes in co-receptor usage or syncytia phenotype. Phylogenetic analyses revealed an accumulation of mutations over time, as well as the reappearance of ancestral lineages. In the infant C2-V4 region of Env, neither the median number of putative N-glycosylation sites or median sequence length showed consistent increases over time. The infant possessed neutralizing antibodies at birth, but these decreased in effectiveness or quantity with time. De novo humoral responses were detected in the child after 12 months, and corresponded with an increase in Env diversity.

conclusionOur study demonstrates a correlation between HIV-1 Env evolution and the humoral immune response. There was an increase in genetic diversification in the infant viral sequences after 12 months, which coincided with increases in neutralizing antibody titers. In addition, episodes of viral growth and successive immune reactions in the first 5-6 years were observed in this slow progressor infant with delayed onset of AIDS. Whether this pattern is typical of slow progressing subtype C HIV-1 infected infant needs to be further substantiated.

Indexed as

Genes, envAcquired Immunodeficiency SyndromeAdultChild, PreschoolDisease ProgressionEvolution, MolecularHIV-1HIV AntibodiesHumansInfantInfectious Disease Transmission, VerticalNeutralization TestsReceptors, CCR5Virus ReplicationHIV AntibodiesReceptors, CCR5

Identifiers

PMID16274482
PMCPMC1308862
OpenAlexW2096003181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.